• Investment World
• eWorld
• Catalyst
• Mentor
• Life
• Canvas
• Praxis
• Urban Pulse
• Brand Quest

Stocks

• Quotes
• SE Diary
• Scoreboard
• Open-End Mutual Fund

Cross Currency

• Rates
  
  

Shipping

• Ports
  
  

Archives

• Yesterday
• Datewise
• Resources

Group Sites

• The Hindu
• Business Line
• Sportstar
• Frontline
• The Hindu eBooks
• The Hindu Images

The National Pharmaceutical Pricing Authority Rulings and Drug Policy implementation during the last two decades as regards essential drugs have not prevented pharmaceutical companies from being globally competitive. Pharmaceutical companies should realise their social obligations to economically weaker sections of the society in providing essential drugs.

Price control should not be based on average past costs. Pricing policies of essential and non-essential drugs need to be investigated and the pricing formulae for essential drugs should be evolved taking into account future costs and savings.

Ramachandran Mahadevan

Bangalore

Letters to the editor and contributions can be sent by e-mail to:bleditor@thehindu.co.in

More Stories on : Letters | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page

Stories in this Section
Tinkering with tariffs

Copyright © 2004, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line